People with prediabetes tend to show higher-than-normal-range numbers on an A1C, fasting glucose, or oral glucose tolerance tests
North America, particularly the United States, dominates the global GLP-1 receptor agonist market
Sci Adv (2017) 3(11):eaao5268
Between curbing addictive cravings to possibly managing mood disorders to offering neuroprotective benefits, GLP-1Ras are the way making way
Because Saxenda acts peripherally and centrally on metabolic pathways, whilst sertraline modulates neurotransmitter activity, their primary therapeutic targets do not overlap, reducing the likelihood of direct pharmacological interaction
Because the moment you use it, it ceases to be just a diluent